ERBB2 and breast cancer: Intriguingly, although we initially identified S100A8/A9 as a prognostic factor among TNBC patients, we also found that its prognostic significance persisted when all BC subtypes were analyzed, including the samples positive for HER2 and hormone receptors (Supplementary Fig. 1c).